Fox Run Management »

Enliven Therapeutics shares owned by Fox Run Management

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Fox Run Management from 13F filings

Historical chart of Fox Run Management investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Fox Run Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Fox Run Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $192k 12k 15.40

More positions owned by Fox Run Management

Select Sector Spdr Tr State Street Fin (XLF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Zebra Technologies Corporati Cl A (ZBRA)
Blackrock (BLK)
Ralph Lauren Corp Cl A (RL)
Roblox Corp Cl A (RBLX)
Wabtec Corporation (WAB)
Hubspot (HUBS)
Garmin SHS (GRMN)
Rockwell Automation (ROK)
Jfrog Ord Shs (FROG)
Godaddy Cl A (GDDY)
Northrop Grumman Corporation (NOC)
Msci (MSCI)

View all positions for Fox Run Management

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
Commodore Capital
Vestal Point Capital
Fairmount Funds Management
BlackRock
Polar Capital Holdings
VR Adviser
Vanguard Group
Henderson Group
Point72 Asset Management
Novo A/S
Blackstone Group
Capital Research Global Investors
Pictet Asset Management Holding SA

View all funds holding Enliven Therapeutics